Astraveus

Astraveus is developing the next generation of cell and gene therapy (CGT) manufacturing solutions. Astraveus' Cell Foundry miniaturizes and automates cell and gene therapy manufacturing within a unique modular end-to-end microfluidic solution that mimics the elegance of natural systems. Deep process optimization of the platform enables higher precision, making it easier to replicate optimal manufacturing, delivering better therapies in a more cost-effective and time-efficient manner, using fewer materials and reducing environmental impact. Today, the full potential of cell and gene therapies is limited by high costs and restricted throughput; this transformative solution has the potential to enable a therapeutic revolution at scale, helping thousands of patients worldwide who need these life-saving therapies gain access to them.